TransCode Therapeutics CEO Letter to Shareholders

BOSTON, July 05, 2023 -- Dear TransCode Therapeutics Shareholders, I want to express the optimism that permeates the management, board, and staff of TransCode as we navigate the ever-evolving...

Related Keywords

Boston ,Massachusetts ,United States ,R Michael Dudley ,Alan Freidman ,Transcode Therapeutics Inc ,University Of Texas Medical Center ,Md Anderson Cancer Center ,Globenewswire Inc ,Dana Farber Cancer Center ,Exchange Commission ,Transcode Therapeutics Shareholders ,Code Therapeutics ,Farber Cancer Center ,Cancer Center ,Texas Medical Center ,Orphan Drug Designation ,Rare Pediatric Disease Designation ,Priority Review Voucher ,Rare Pediatric Disease Priority Review Voucher ,Executive Officer ,Private Securities Litigation Reform Act ,Investigational New Drug ,Annual Report ,